Articles

Following 'regulations'

CRISPR study by Sanger Institute researchers and colleagues reveals new immune system regulators
Written byJeffrey Bouley
| 3 min read

HINXTON, U.K.—In some interesting CRISPR-related news, recent research (published Jan. 10 in the journal Cell) has led to a map of T cell regulation that could aid development of drugs that could activate the immune system. CRISPR is a gene-editing technology that enables researchers to cut DNA at any position in the genome, to create mutations and switch off specific genes, with CRISPR/Cas9 being the most commonly used technology right now.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.